ENSURE PLUS ADVANCE: STRONGER PATIENTS, SIGNIFICANT SAVINGS*§#1-3

The NHS 10-Year Health Plan prioritises prevention, community-based care, and reducing avoidable hospital use. Malnutrition and muscle loss work against all three, driving higher admissions, GP appointments, and poorer outcomes.4-10

Ensure Plus Advance -  is backed by real-world evidence showing reductions in hospital admissions, readmissions, and healthcare costs.*§#1,2

icon

MALNUTRITION AND MUSCLE LOSS: 

A HIDDEN DRIVER OF POOR OUTCOMES AND INCREASED HEALTHCARE COSTS

Malnutrition and muscle loss can have significant consequences on patient and clinical outcomes.

Increased risk of falls and fractures7,8

More GP appointments11

Additional hospital admissions7,11

Increased length of stay10,11

Higher readmission rates10

This can place a substantial burden on healthcare resources, with additional annual per patients costs of:

£7,408

for malnourished patients12

£2,707

for muscle weakness13

But new clinical evidence shows that treating patients with Ensure Plus Advance can help alleviate this burden, improving patient outcomes, and reducing healthcare resource use and costs.*§#1-3

ENSURE PLUS ADVANCE: SIGNIFICANTLY REDUCES HEALTHCARE RESOURCE USE AND COSTS*†§#1,2

Ensure Plus Advance, with it's unique blend of high-protein, HMB and vitamin D, proven to protect and preserve muscle mass and increase muscle strength,‡¶^^14-16 is backed by real-world evidence from two studies demonstrating substantial reductions in healthcare resource use and costs compared to other oral nutritional supplements.*§#1,2

Group 23 image Community care: Ensure Plus Advance Lowers healthcare resource use

Various patient cohorts*§§#2,17 

Hospital
admissions

GP
visits

Emergency department 
visits

Cancer patients†§§#2,17

Hospital
admissions

GP
visits

Emergency department 
visits

Potential annual per-patient savings in the UK:

The reductions in community service utilisation seen with Ensure Plus Advance could translate into potential savings in the UK, aligning with the NHS 10-Year Plan’s ambition toward prevention and proactive health management.:2,4,17-23

Potential savings:

Various patient cohorts◊** 

Up to 2.95

fewer hospital
bed days

Up to £4,123

potential saved
costs

Cancer patients‖##

Up to 3.8

fewer hospital
bed days

Up to £5,371

potential saved
costs

Hospital care: Ensure Plus Advance Significantly reduceS readmissions§#3

readmissions at one month

readmissions at three months

readmissions at six months

Potential annual per-patient savings in the UK:

Reducing hospital readmissions could potentially save hospital bed days and costs, supporting the NHS 10 year plan by keeping care in the community and more patients out of hospital:¶¶3,4,22,23

Up to 2.5

fewer hospital
bed days

Up to £3,423

potential costs 

saved

GIVE YOUR PATIENTS THE RIGHT NUTRITION TO SUPPORT THEIR RECOVERY, WITH A UNIQUE BLEND OF INGREDIENTS FOR MUSCLE-TARGETED NUTRITION

Ensure Plus Advance is a 220 ml, ready to drink ONS. It contains a unique blend of protein, vitamin D and HMB that is proven to protect and preserve muscle mass, strength and function.~‡‡††14-16

The key nutrients found in Ensure Plus Advance's unique blend can increase muscle strength:

Protein

Adequate protein intake is essential to help minimise declines in strength and function.24 Protein can also help reduce complications such as infections and can help improve weight.25

HMB

HMB is a metabolite of leucine, a branched-chain essential amino acid exclusively obtained from dietary sources.26

Vitamin D

Vitamin D acts directly on muscle to promote its function through specific vitamin D receptors found on muscle cells27

Support muscle strength in your patients, prescribe Ensure Plus Advance

Ensure Plus Advance is available in 5 delicious flavours and is the most loved high protein ONS.Σ28,29

Try the Ensure Plus Starter Pack. It contains two bottles of the vanilla flavour and one bottle of each of the four other flavours, a downloadable recipe book, and a flavour choice card.

Footnotes:

ONS - Oral nutritional supplements.

*Retrospective database review of 283 patients (63% with cancer) who received 2 daily servings of Ensure Plus Advance or other oral nutritional supplements (The supplements that were used by the other ONS group contained 206–320 kcal, 10.7–20 g protein, 7.8–13 g fat, and 25.5–37.7 g carbohydrates) in combination with dietary counselling and exercise for 3-6 months.

Retrospective database review of 179 patients with cancer who received 2 daily servings of Ensure Plus Advance or other oral nutritional supplements (the supplements that were used by the other ONS group contained 206–320 kcal, 10.7–20 g protein, 7.8–13 g fat, and 25.5–37.7 g carbohydrates) in combination with dietary counselling and exercise for 3-6 months.

§Retrospective database review of more than 16,000 patients who received 2 daily servings of Ensure Plus Advance (n=720) or standard oral nutritional supplements (n=720) during hospitalisation.
#Compared to other ONS.

^Yearly cost of malnutrition and muscle loss. Cost worked out on the basis of annual malnutrition cost to the NHS of £23.5bn6 and annual excess cost of muscle loss in the UK of £2.5bn9

As shown in a randomised control trial to investigate the effects of a specialised ONS on older women (≥65 years) who underwent surgery for hip fracture vs. standard postoperative nutrition. Muscle function was measured by handgrip strength.

Ensure Plus Advance was shown to preserve muscle mass in elderly patients after hip fracture surgery with rehabilitation, when consumed twice a day for 30 days, as compared to standard care.

^^Strength was measured by handgrip strength in a post hoc analysis of over 600 malnourished people with heart or lung diseases, age 65 or older. Ensure Plus Advance was consumed twice daily for 90 days. 

§§Comparative figures showed the % difference for those receiving Ensure Plus Advance vs. those receiving other ONS in the 12 months after the intervention.

Estimated NHS cost savings have been calculated by applying average percentage reductions in healthcare use from Cornejo 2025 to published UK NHS utilisation and cost figures. Retrospective analysis from the study reported 28.1% fewer GP visits, 38.7% fewer ED visits, and 50.8% fewer hospital admissions.2,17 Reductions were multiplied by UK averages (0.24 ED visits/year,18,19 3.3 GP visits/year,20 0.7 admissions/year21 with 8.3 bed days per admission22) and converted using typical NHS unit costs (£37 per GP visit,18 up to £563 per ED visit,18 £1,369 per hospital bed day23). This equates to a potential saving of approximately £4,123 per patient per year. Actual costs may vary depending on investigations, appointment duration, and local tariffs.

**Hospital bed-day savings were estimated by applying Cornejo 2025 admission reduction (50.8%)2,17 to UK averages (0.7 admissions/year;21 8.3 days per stay22) = 2.95

||Estimated NHS cost savings have been calculated by applying average percentage reductions in healthcare use from Cornejo 2025 to published UK NHS utilisation and cost figures. Retrospective analysis from the study reported 36.2% fewer GP visits, 52.7% fewer ED visits, and 66.1% fewer hospital admissions.2,217 Reductions were multiplied by UK averages (0.24 ED visits/year,18.19 3.3 GP visits/year,20 0.7 admissions/year21 with 8.3 bed days per admission22) and converted using typical NHS unit costs (£37 per GP visit,18 up to £563 per ED visit,18 £1,369 per hospital bed day23). This equates to a potential saving of approximately £5,371 per patient per year. Actual costs may vary depending on investigations, appointment duration, and local tariffs.

##Hospital bed-day savings were estimated by applying Cornejo 2025 admission reduction (66.1%)2,17 to UK averages (0.7 admissions/year;21 8.3 days per stay22) = 3.8.

¶¶Figures from Frishman 2025 are based on 30% reduction in hospital admissions at one month,3 which have been applied to UK healthcare costs to estimate average potential UK savings. Costs may vary depending on  investigation level, hospital duration, types of admission, and  treatment received. Hospital admission costs are calculated using the  average length of stay (8.3 days, 2022 data)18 multiplied by the average bed-day cost (£1,369), derived from elective, non-elective, critical  care, and standard bed-day costs.23 Estimated savings: Hospital bed days (2.5) hospital admissions costs (£3423).

~As shown in a randomised control trial to investigate the effects of a specialised ONS on older women (≥65 years) who underwent surgery for hip fracture vs. standard postoperative nutrition. Muscle function was measured by handgrip strength. 

‡‡Ensure Plus Advance was shown to preserve muscle mass in elderly patients after hip fracture surgery with rehabilitation, when consumed twice a day for 30 days, as compared to standard care. 

††Strength was measured by handgrip strength in a post hoc analysis of over 600 malnourished people with heart or lung diseases, age 65 or older. Ensure Plus Advance was consumed twice daily for 90 days.

Σ Ensure Plus Advance is the most loved high-protein ONS vs Fortisip Compact Protein and Fresubin PRO COMPACT. Research in healthy adults who were asked to drink comparative flavours of Ensure Plus Advance and Fortisip Compact Protein (243 people; 49% vs 41% respectively “loved the taste”), and of Ensure Plus Advance and Fresubin PRO COMPACT (234 people; 55% vs 45% respectively “loved the taste”). In both studies, participants who gave then overall taste of the drink a 6, 7, 8 or 9 out of 9 (where 1 = I extremely dislike it and 9 = I like it extremely) were directly asked if they “loved the taste”; those who responded lower were assumed as responding no, with that response included in overall reported statistics.

References:

  1. Cornejo-Pareja et al. Nutrients. 2021;13(12):4355.
  2. Cornejo-Pareja IM et al. Nutrients 2025;17:2854
  3. Frishman S et al. Clin Nutr 2025;17:3511
  4. NHS, 2025. Fit for the Future: 10 Year Health Plan for England, Available online: https://www.gov.uk/government/publications/10-year-health-plan-for-england-fit-for-the-future Last accessed December 2025
  5. Volkert D et al. Clin Nutr 2019;38:10-47
  6. Cederholm T et al. Clin Nutr 2017;36:49-64
  7. Cruz-Jentoft AJ et al. Age and Ageing 2019;48:16-31
  8. Argiles JM et al JAMADA 2016;17-789-796
  9. Malnutrition Pathway, 2021. Sarcopenia: loss of muscle mass. A healthcare professional factsheet. Available online: https://www.malnutritionpathway.co.uk/library/factsheet_sarcopenia.pdf Last accessed May 2024
  10. Deutz NEP et al. JAMADA 2019;20:22-27
  11. Malnutrition Task Force, 2013. A review and summary of the impact of malnutrition in older people and the reported costs and benefits of interventions. Available online: https://ilcuk.org.uk/wp-content/uploads/2019/01/Costs-Benefits_Report_Jun13.pdf Last accessed May 2025.
  12. Malnutrition Pathway, 2021. Managing Adult Malnutrition in the Community. Available online: https://www.malnutritionpathway.co.uk/library/managing_malnutrition.pdf Last accessed May 2025
  13. Pinedo-Villanueva R et al. Calcif Tissue Int 2019;104:137–144.
  14. Malafarina V et al. Maturitas 2017;101:42-50
  15. Matheson EM et al. Clin Nutr 2021;40(3):844-849
  16. Ekinci O et al. Nutr Clin Pract 2016;31(6):829-835
  17. Data on File. Based on a post hoc analysis of Cornejo-Pareja I et al. Nutrients 2025, 17, 2854.
  18. The Kings Fund, 2025. Key facts and figures about the NHS. Available online: https://www.kingsfund.org.uk/insight-and-analysis/data-and-charts/key-facts-figures-nhs?utm_source=chatgpt.com Last accessed December 2025.
  19. Office for National Statistics, 2025. Population estimates for the UK, England, Wales, Scotland and Northern Ireland: mid-2024. Available online: Last accessed December 2025\
  20. University of Manchester, 2021. Four in ten consultations at GP clinics were with frequent attenders. Available online: https://www.manchester.ac.uk/about/news/four-in-ten-consultations-at-gp-clinics-were-with-frequent-attenders/ Last accessed December 2025
  21. Kolovos S et al. Journal of Bone Oncology 2019;17:100243
  22. The Health Foundation, 2023. Longer hospital stays and fewer admissions. Available online: https://www.health.org.uk/reports-and-analysis/briefings/longer-hospital-stays-and-fewer-admissions#:~:text=Average%20length%20of%20stay%20in,to%205.1%20days%20(3%25). Last accessed December 2025
  23. UK Parliament, 2023. Hospital Beds: Costs. Available online: https://questions-statements.parliament.uk/written-questions/detail/2023-03-14/165361 Last accessed December 2025
  24. Deutz NE. et al. Clin Nutr 2014;33(6):929-936.
  25. Cawood AL. et al. Ageing Res Rev 2012;11(2):278-296
  26. Wilson GJ. et al. Nutr Metab 2008;5:1
  27. Wagatsuma A. and Sakuma K. Biomed Res Int 2014;2014:121254
ANIEMEA-P-GB-202502858  |  December 2025
Order ID: #12345
Order Date: 01/05/2024
Product Product Flavour Product Quantity
Click here to add this page to your bookmarks.

This page has been added to your bookmark. To access your bookmark list, Click here

Loading...

Please wait, system loading    

SESSION TIMEOUT

Your session is about to expire in {min} minutes and you will be logged out. Do you wish to stay logged in?
UK-N/A-2400058 (V8) | October 2024

Please log in to continue

Thanks for registering. To begin, please log in to your ProConnect account. After you log in, you’ll have temporary access to all resources and education while we verify your details.

UK-N/A-2400058 (v9) | October 2025

JOIN ABBOTT'S GROWING NETWORK OF HEALTHCARE PROFESSIONALS

Sign up to receive marketing and medical communications from Abbott

Fields marked with an asterisk (*) are mandatory.   

Please enter a valid first name Please enter a first name Please do not add space or special characters on the field
Please enter a valid last name Please enter a last name Please do not add space or special characters on the field
Please enter a valid contact number starting with +44 Please enter a contact number Please enter a valid contact number starting with +44
Please enter a valid email address Please enter an email address Please enter a valid email address
Please enter a valid email address Please confirm your email address Please enter a valid email address
Please enter a valid email address Please enter a valid email address
Please enter a valid email address Please enter a valid email address
 
 
Please select an area of specialty
Only Select a UK place of work. If unable to select/locate one, please fill in manually in Place of Work/Trust. Please enter a valid postcode using the correct format (see information icon above). Please enter a postcode Please enter a valid postcode using the correct format (see information icon above).
Please enter a place of work/trust Please enter a place of work/trust Please enter valid work / trust. Do not use special characters in this box.
Please enter valid address Please enter a street Please enter valid street. Do not use special characters in this box.
Please enter valid city Please enter a city Please enter valid city. Do not use special characters in this box.
Please enter valid county Please enter a county Please enter valid county. Do not use special characters in this box.
Password does not follow password guidelines Please enter a password Password must have at least 8 characters, 1 number, and 1 special character

Password Requirements

Incorrect i18nKey: password-missing-criteria-error
Password must match Please confirm your password

Abbott would like to use your personal data to send to you emails on scientific and educational information, invitations to events, surveys and other relevant communications from Abbott (the “Purpose”). Abbott will not sell or transfer your personal information. Unless you have expressly consented, Abbott will not use it for any other purpose other than the Purpose. To be removed from the Abbott mailing list, you may unsubscribe at any time by managing your preferences in the 'my account' section. Access Abbott's Privacy Policy to learn more about how your data is managed.

 
Please agree to the site's terms of use
 
Please agree to the site's terms of use

Have an account? Login Here

Success or error message

Sorry there has been an error in your registration, please contact our customer service team email: abbott.customerservices@nhs.net
Sorry there has been an error in your registration, please contact our customer service team email: abbott.customerservices@nhs.net
You have registered for an account using abc@gmail.com, however you have not yet activated your account. Please check your inbox for an email from proconnect@abbott.com to activate your account
You might already have an account with ProConnect. abc@gmail.com. Please try and login.
An account associated with abc@gmail.com is already approved and active. Please log in to continue. If you've forgotten your password, reset it here.

UK-N/A-2400058(v9) | September 2025

  • step 1 of 10:Welcome,current
  • step 2 of 10:1,Pending
  • step 3 of 10:2,Pending
  • step 4 of 10:3,Pending
  • step 5 of 10:4,Pending
  • step 6 of 10:5,Pending
  • step 7 of 10:6,Pending
  • step 8 of 10:7,Pending
  • step 9 of 10:8,Pending
  • step 10 of 10:Thank you,Pending
 

Your feedback matters

Please take a quick minute to share your thoughts and help us make your experience even better.

 

Proconnect:

We Value Your Voice - Make Proconnect Work for You

1/8

 
 

Proconnect:

We Value Your Voice - Make Proconnect Work for You

2/8

 
 

Proconnect:

We Value Your Voice - Make Proconnect Work for You

3/8

 
 

Proconnect:

We Value Your Voice - Make Proconnect Work for You

4/8

On a scale of 1 to 5, where 1 is very unsatisfied and 5 is very satisfied, please rate your satisfaction with the following statements.

 
 

Proconnect:

We Value Your Voice - Make Proconnect Work for You

5/8

On a scale of 1 to 5, where 1 is very unsatisfied and 5 is very satisfied, please rate your satisfaction with the following statements.

 
 

Proconnect:

We Value Your Voice - Make Proconnect Work for You

6/8

On a scale of 1 to 5, where 1 is very unsatisfied and 5 is very satisfied, please rate your satisfaction with the following statements.

 
 

Proconnect:

We Value Your Voice - Make Proconnect Work for You

7/8

On a scale of 1 to 5, where 1 is very unsatisfied and 5 is very satisfied, please rate your satisfaction with the following statements.

 
 

Proconnect:

We Value Your Voice - Make Proconnect Work for You

8/8

 

0 = Not likely at all | 4 = Very likely

 

Thank you

 

 Added to Bag

ENSURE PLUS

1 x 220 ml

Flavor: Apple

UK-N/A-2400058 (V9) | October 2025

1,5 kcal / ml

Nutrition Information

Energy
 UnitPer {ml-col-1} mlPer {ml-col-2} ml
 
Vitamins
 UnitPer {ml-col-1} mlPer {ml-col-2} ml
 
Minerals
 UnitPer {ml-col-1} mlPer {ml-col-2} ml
 

footnotes

Product details not available.

 

YOUR ACCOUNT IS PENDING APPROVAL

You have {liteUserDaysLeft} business days of temporary access.
Based on your email address {email} your account has not yet been approved. We’re validating your credentials. You won’t be able to order samples until your account is approved and activated. Please check your email for more details. For help, contact us at abbott.proconnect_access@nhs.net.

UK--2500192 | September 2025

 

ACTIVATION REQUIRED TO GAIN FULL ACCESS

You have {liteUserDaysLeft} business days of temporary access.
Based on your email address {email} your credentials are validated but not yet activated. To gain full access, including the ability to order samples, click the activation link we sent to your inbox. For help, contact us at abbott.proconnect_access@nhs.net.

UK--2500192 | September 2025

WANT TO READ MORE?

Register to continue reading this article

UK-N/A-2400058(v9) | September 2025